new
member
recent
discov
interferon
ifn
famili
produc
predominantli
matur
dendrit
cell
macrophag
implic
numer
immunolog
respons
shown
antivir
activ
similar
type
interferon
although
target
cell
popul
limit
type
interferon
recent
year
role
pathogenesi
variou
cancer
also
extens
studi
review
discuss
recent
advanc
immunolog
process
pathogenesi
variou
cancer
respect
donnelli
kotenko
witt
et
al
kotenko
et
al
three
cytokin
usual
describ
unison
ifn
titl
differ
distinguish
nearli
structur
ident
structur
uniqu
fuji
numasaki
potent
ifn
molecul
human
well
abund
ifn
molecul
serum
despit
exist
pseudogen
mice
donnelli
kotenko
alborzi
et
al
ham
et
al
lasfar
et
al
maher
et
al
interestingli
also
human
ifn
molecul
display
nlink
glycosyl
donnelli
kotenko
previous
discov
well
understood
interferon
consist
type
interferon
includ
thirteen
subtyp
human
type
ii
interferon
whose
sole
member
elucid
role
interferon
includ
antivir
antiprolif
immunomodulatori
activ
induc
effect
vari
depend
cell
type
act
upon
de
weerd
et
al
platania
ifn
shown
exhibit
antivir
antiprolif
activ
produc
signal
pathway
util
donnelli
kotenko
kotenko
et
al
although
effect
seen
limit
extent
compar
vast
array
cell
type
influenc
type
interferon
donnelli
kotenko
witt
et
al
brand
et
al
cellular
target
ifn
appear
primarili
epitheli
origin
wherea
effect
absent
broad
rang
cell
typic
affect
type
interferon
leukocyt
donnelli
kotenko
witt
et
al
kotenko
et
al
meager
et
al
also
despit
signal
pathway
use
type
interferon
doyl
et
al
dumouti
et
al
jordan
et
al
oshea
et
al
recent
cdna
microarray
analys
indic
gene
pattern
express
type
iii
essenti
jordan
et
al
two
interferon
type
act
differ
heterodimer
cell
receptor
type
receptor
ifnar
includ
type
ii
receptor
ifngr
includ
type
iii
receptor
includ
de
weerd
et
al
donnelli
et
al
yoon
et
al
fact
discoveri
ifnlr
receptor
ligand
appar
rel
molecul
instig
discoveri
ifn
receptor
also
util
cytokin
includ
signal
induc
pleiotrop
effect
includ
protect
hyperact
immun
respons
immun
respons
activ
epitheli
cell
yoon
et
al
wolk
et
al
xu
et
al
discoveri
type
iii
interferon
open
new
chapter
interferon
studi
due
potent
type
iii
interferon
cytokin
interest
review
studi
indic
abil
serv
mediat
innat
adapt
immun
respons
furthermor
specif
target
limit
scope
cell
type
could
allow
use
therapeut
treatment
decreas
side
toxic
accompani
type
interferon
therapi
egli
et
al
multipl
studi
also
indic
involv
pathogenesi
cancer
well
antitumor
effect
meager
et
al
review
discuss
recent
advanc
immunolog
cancer
research
gene
encod
fellow
type
iii
interferon
locat
chromosom
distantli
relat
type
interferon
gene
donnelli
kotenko
kotenko
et
al
member
famili
short
structur
protein
contain
six
seven
alpha
helic
arrang
antiparallel
configur
amino
acid
length
pestka
et
al
mannino
et
al
express
involv
viralinduc
signal
pathway
onoguchi
et
al
cell
type
express
high
level
includ
matur
dendrit
cell
macrophag
mast
cell
alveolar
cell
wolk
et
al
et
al
mennechet
wang
et
al
due
similar
signal
mechan
induc
type
type
iii
interferon
dendrit
cell
shown
coexpress
ifn
albeit
everi
cell
type
express
present
nearli
everi
cell
type
ifn
express
mostli
promin
tissu
epithelia
infect
express
accompani
express
infect
tissu
brain
spinal
cord
mennechet
sommereyn
et
al
primarili
target
epitheli
cell
high
level
therefor
present
infect
gi
respiratori
tract
mucos
region
et
al
sommereyn
et
al
iversen
et
al
swider
et
al
lazear
et
al
studi
witt
et
al
demonstr
target
skin
cell
includ
keratinocyt
melanocyt
endotheli
cell
subcutan
adipocyt
fibroblast
target
witt
et
al
immun
cell
shown
less
sensit
despit
express
appropri
ifn
receptor
witt
et
al
accredit
presenc
splice
variant
ifnlr
receptor
secret
immun
cell
secret
glycosyl
protein
moder
bind
thu
inhibit
effect
vitro
experi
conduct
doyl
et
al
show
human
hepatocyt
could
also
target
redund
signal
cascad
gene
express
type
type
iii
interferon
may
attribut
altern
cell
type
target
type
iii
interferon
therapi
may
benefici
oppos
type
interferon
therapi
due
specif
particular
cell
type
oppos
mani
differ
cell
popul
therapi
could
possibl
specif
target
toward
epitheli
tissu
liver
exclud
toxic
effect
endotheli
cell
central
nervou
system
kidney
spleen
seen
type
interferon
effect
sommereyn
et
al
type
interferon
activ
jakstat
signal
pathway
induct
also
display
albeit
lesser
degre
kotenko
et
al
doyl
et
al
dumouti
et
al
jordan
et
al
oshea
et
al
zhou
et
al
signal
cascad
transpir
follow
tyrosin
residu
phosphoryl
protein
dimer
subsequ
transport
nucleu
transport
dimer
combin
interferon
regulatori
factor
form
interferonstimul
gene
factor
complex
darnel
et
al
nucleu
complex
bind
interferonstimul
respons
element
isf
induc
interferonstimul
gene
transcript
maher
et
al
signal
pathway
primari
signal
pathway
type
interferon
antivir
respons
occur
immedi
day
follow
viral
infect
steen
gamero
induct
isf
induc
transcript
hundr
gene
involv
antivir
respons
notabl
antivir
gene
exampl
includ
oa
ifit
diamond
farzan
platania
fish
gene
express
array
analys
demonstr
similar
gene
subset
induc
type
interferon
reiter
differ
cell
type
two
differ
interferon
exert
effect
cellular
target
limit
due
absenc
ifnlr
compon
receptor
mani
cell
type
sommereyn
et
al
zhou
et
al
must
also
mention
auxiliari
signal
cascad
investig
ifn
brand
et
al
show
ifn
activ
map
kinas
mapk
cascad
intestin
epitheli
cell
mapk
akt
signal
induc
colon
tissu
studi
compar
studi
shown
discrep
particular
mapk
activ
ifn
futur
experiment
need
elucid
role
mapk
ifn
signal
zhou
et
al
role
immun
role
cytokin
product
studi
liu
et
al
show
scenario
ifnalpha
contrast
effect
stimul
caus
increas
tolllik
receptor
tlr
stimul
secret
monocytederiv
macrophag
exhibit
effect
tlr
induc
secret
monocyt
monocytederiv
dendrit
cell
explain
presenc
ifnlr
receptor
monocytederiv
macrophag
oppos
receptor
lack
monocytederiv
dendrit
cell
monocyt
contrarili
shown
downregul
tlr
induc
secret
monocytederiv
macrophag
studi
indic
mediat
effect
tcell
microorgan
produc
ligand
bind
tlr
antigenpres
cell
induc
secret
mediat
immun
respons
polar
cell
cell
hay
et
al
trinchieri
gerosa
cell
play
critic
role
clearanc
infect
secret
activ
macrophag
produc
cellmedi
phagocyt
immun
respons
romagnani
studi
liu
et
al
also
show
increas
respons
macrophag
thu
enhanc
immun
respons
contrast
suppress
respons
macrophag
stimul
byrn
et
al
mcrae
et
al
peripher
blood
mononuclear
cell
induc
secret
high
level
accompani
moder
level
geldhof
et
al
involv
proinflammatori
respons
predominantli
involv
chemotaxi
neutrophil
transit
innat
respons
adapt
respons
recruit
monocyt
macrophag
lymphocyt
baggiolini
clarklewi
kaplanski
et
al
function
promot
prolifer
differenti
antibodysecret
bcell
also
suppress
tcell
respons
proinflammatori
effect
monocyt
macrophag
mannino
et
al
kaplanski
et
al
itoh
hirohata
levi
brouet
rousset
et
al
must
note
induc
cytokin
secret
level
vari
individu
pattern
secret
remain
consist
jordan
et
al
role
allerg
asthma
elucid
sever
recent
studi
shown
attenu
asthma
inflammatori
respons
increas
prolifer
tregulatori
cell
well
inhibit
increas
presenc
tregulatori
cell
better
control
hyperact
immun
respons
proinflammatori
cytokin
produc
cell
respons
infect
shown
play
critic
role
airway
inflamm
bronchial
asthma
koch
finotto
sriniva
et
al
willskarp
anoth
cytokin
involv
asthma
inflamm
also
inhibit
thought
induc
cell
secret
proinflammatori
cytokin
jordan
et
al
gallagh
et
al
sharma
matsui
interestingli
contradictori
studi
et
al
indic
may
actual
involv
pathogenesi
allerg
airway
reaction
due
induct
proinflammatori
cytokin
et
al
receptor
activ
nuclear
factor
kb
rankl
shown
play
role
differenti
osteoclast
osteoclast
identifi
primari
player
bone
resorpt
lead
bone
joint
disrupt
rheumatoid
arthriti
tanaka
knowledg
research
set
target
rankl
pathway
attempt
treat
rheumatoid
arthriti
past
studi
shown
level
elev
blood
synovium
rheumatoid
arthriti
patient
cytokin
enhanc
inflammatori
respons
induc
secret
xu
et
al
recent
studi
xu
et
al
confirm
directli
induc
rankl
pathway
target
inhibit
suggest
new
rheumatoid
arthriti
treatment
xu
et
al
upregul
express
mhc
class
molecul
cell
observ
implic
antivir
capabl
mhc
class
upregul
increas
immun
system
abil
recogn
virus
donnelli
kotenko
kotenko
et
al
huang
et
al
provid
proof
upregul
mhc
class
place
presenc
glycoprotein
secret
yabalik
diseas
viru
yatapoxviru
known
inhibit
antivir
respons
type
interferon
experi
show
also
inhibit
upregul
mhc
class
subsequ
antivir
immun
respons
inhibit
put
presenc
resist
yatapoxviru
display
indic
cytokin
antivir
properti
huang
et
al
differ
observ
skin
protect
capabl
subject
psoriasi
atop
dermat
skin
disord
weaken
skin
presenc
psoriat
lesion
make
lesion
less
prone
viral
infect
atop
dermat
lesion
lack
presenc
wolk
et
al
natur
killer
nk
cell
possess
special
machineri
allow
target
lyse
foreign
alter
cell
independ
activ
antigen
present
cell
zamai
et
al
role
augment
abil
nk
cell
recogn
target
cell
led
kramer
et
al
discov
indirect
link
secret
nk
cell
activ
geldhof
et
al
et
al
kramer
et
al
conduct
test
knowledg
nk
cell
express
ifnlr
receptor
recent
experi
souzafonsecaguimara
et
al
detect
presenc
ifnlr
mrna
rtpcr
purifi
mice
nk
cell
first
time
ifn
shown
directli
influenc
nk
cell
numer
experi
implic
antivir
activ
plethora
virus
instanc
target
hepat
cell
make
potenti
therapeut
agent
toward
hepat
virus
doyl
et
al
marcello
et
al
multipl
experi
indic
signific
presenc
hcv
infect
appar
provid
antivir
defens
independ
type
interferon
diegelmann
et
al
lee
et
al
park
et
al
kanda
et
al
demonstr
inhibit
intern
ribosom
entri
site
mediat
translat
hcv
hav
studi
also
show
hbv
often
caus
chronic
liver
inflamm
also
induc
increas
express
et
al
show
promot
spontan
seroconvers
hepat
b
e
antigen
hbea
mark
increas
antihbea
thu
provid
subsequ
hbv
clearanc
liaw
yu
et
al
almeida
et
al
demonstr
antivir
capabl
member
bunyavirida
famili
without
assist
type
interferon
fact
addit
type
interferon
unnecessari
enhanc
antivir
activ
bunyaviru
de
freita
almeida
et
al
ank
et
al
show
potenc
antivir
respons
select
singl
strand
rna
virus
includ
encephalomyocard
viru
vesicular
stomat
viru
studi
also
elucid
mechan
antivir
respons
discov
antivir
respons
much
stronger
vivo
oppos
vitro
enhanc
serum
level
observ
led
suggest
mechan
lie
stimul
immun
respons
oppos
direct
induct
antivir
state
ank
et
al
studi
viral
respiratori
infect
indic
major
interferon
produc
type
ii
alveolar
cell
respons
sarscoronaviru
influenza
viru
wang
et
al
qian
et
al
wang
et
al
recent
year
role
pathogenesi
varieti
cancer
investig
either
induc
tumor
promot
effect
tumor
inhibit
effect
depend
cancer
cell
type
affect
instanc
typic
shown
antitumor
effect
cancer
shown
cytokin
produc
tumor
promot
effect
multipl
myeloma
b
summar
tabl
antiapoptot
factor
suggest
root
caus
uncheck
plasma
cell
prolifer
lymphoma
link
prolifer
plasma
cell
multipl
myeloma
b
although
effect
multipl
myeloma
vari
among
multipl
myeloma
cell
line
alexandraki
et
al
et
al
jourdan
et
al
multipl
myeloma
promot
effect
cytokin
result
investig
effect
cytokin
multipl
myeloma
biolog
studi
novak
et
al
test
role
multipl
myeloma
novak
et
al
despit
usual
display
antivir
antitumor
effect
consid
possibl
myeloma
promotor
share
receptor
similar
util
signal
pathway
similar
shown
multipl
myeloma
cell
inde
express
receptor
bind
solubl
clear
cell
bone
marrow
produc
inde
significantli
increas
level
multipl
myeloma
bone
marrow
compar
regular
bone
marrow
studi
novak
et
al
also
attempt
elucid
exact
signal
pathway
activ
myeloma
cell
found
activ
mapkerk
pathway
myeloma
pathway
util
order
induc
promyeloma
effect
effect
myeloma
occur
result
activ
induc
effect
mapkerk
pathway
similarli
precis
role
myeloma
microenviron
remain
unclear
suggest
dynam
receptor
express
heterodimer
activ
cellspecif
signal
cascad
play
role
effect
multipl
myeloma
also
suggest
promot
myeloma
growth
independ
particip
signal
crosstalk
known
promot
multipl
myeloma
cell
growth
nevertheless
show
protumor
effect
multipl
myeloma
b
ifn
consid
potenti
antitumor
medic
upon
discoveri
due
type
interferonlik
effect
display
fuji
et
al
type
ii
iii
interferon
test
immunotherapi
trial
display
proapoptot
effect
tumor
jiang
zhou
display
antitumor
effect
redund
amongst
interferon
limit
scope
target
cell
type
iii
interferon
may
allow
specif
target
tumor
display
less
sideeffect
compar
type
interferon
fuji
et
al
steen
gamero
specif
epitheli
skin
cell
may
also
bolster
effect
combat
skin
tumor
amongst
skin
cell
discuss
keratinocyt
melanocyt
specif
skin
cell
express
receptor
wolf
et
al
state
growth
keratinocyt
inhibit
wolk
et
al
guenterberg
et
al
show
melanoma
cancer
cell
line
express
ifn
receptor
may
therefor
home
specif
keratinocyt
carcinoma
cell
melanoma
cell
exert
antiprolif
proapoptot
effect
jakstat
signal
pathway
guenterberg
et
al
nichola
lesinski
antitumor
effect
investig
variou
studi
use
melanoma
cell
murin
model
melanoma
line
cell
line
choic
due
aggress
natur
lasfar
et
al
sato
et
al
demonstr
antitumor
effect
cell
murin
mice
trial
upregul
mhc
class
nk
cell
augment
includ
list
discov
antitumor
mechan
merritt
et
al
rome
et
al
cell
cycl
checkpoint
mediat
includ
molecul
retinoblastoma
rb
protein
also
affect
previous
discuss
molecul
increas
level
increas
dephosphoryl
rb
level
also
note
dephosphoryl
rb
exist
differenti
arrest
cell
sato
et
al
yen
varvayani
today
lung
cancer
persist
deadliest
cancer
discuss
specif
target
epitheli
cell
express
respiratori
system
specif
studi
shown
nonsmal
cell
lung
carcinoma
nsclc
patient
display
elev
level
serum
therefor
serum
level
initi
consid
diagnost
measur
nsclc
sinc
discov
provid
antiprolif
effect
upregul
molecul
cell
stat
signal
pathway
fuji
et
al
barrera
et
al
molecul
serv
cyclindepend
kinas
inhibitor
upregul
lead
cell
arrest
apoptosi
abba
dutta
similar
mechan
util
skin
cancer
prolifer
also
upregul
mhc
class
rb
oesophag
carcinoma
cell
line
shown
li
et
al
li
et
al
upregul
rb
protein
evidenc
cell
line
phase
arrest
furthermor
apoptosi
also
evidenc
cleavag
activ
caspas
poli
adpribos
polymeras
involv
apoptot
pathway
esophagu
inhibit
ttn
class
protein
li
et
al
skin
inhibit
class
protein
merritt
et
al
rome
et
al
sato
et
al
yen
varvayani
upregulateincreas
downregulatedecreas
li
et
al
target
nine
human
oesophag
carcinoma
cell
line
specif
express
ifnlr
data
show
accompani
chemotherapi
exhibit
antitumor
effect
toward
oesophag
carcinoma
cell
affect
normal
cell
contrast
also
affect
normal
cell
major
find
indic
may
use
target
specif
epitheli
cell
type
limit
side
effect
caus
type
interferon
recent
studi
demonstr
antiprolif
proapoptot
effect
toward
gastric
adenocarcinoma
cell
line
xuefeng
et
al
infect
gastric
cell
recombin
plasmid
adenoviru
shown
induc
elev
level
human
express
plasmid
transfect
cell
also
demonstr
higher
rate
apoptosi
due
antiprolif
effect
bu
et
al
relat
studi
use
murin
model
infect
cell
also
show
adenoviru
plasmid
inhibit
gastric
cancer
cell
furthermor
studi
indic
induc
possibl
nk
cellmedi
immun
respons
gastric
tumor
bu
et
al
separ
vitro
studi
gao
et
al
show
caus
cell
cycl
arrest
apoptosi
gastric
carcinoma
upregul
bax
downregul
studi
also
highlight
depolar
mitochondria
membran
result
cytochrom
c
apoptosisinduc
factor
releas
subsequ
activ
proapoptot
caspas
cascad
gao
et
al
lu
et
al
recent
discov
antiprolif
effect
cancer
enhanc
creat
mutant
sitedirect
mutagenesi
techniqu
human
mutant
shown
display
enhanc
antitumor
activ
ileocec
adenocarcinoma
line
previous
discuss
gastric
adenocarcinoma
line
lu
et
al
find
indic
mutant
may
even
stronger
immunotherapi
treatment
prospect
compar
nativ
sato
et
al
also
test
effect
mice
colorect
cancer
mice
ectop
implant
tumor
cell
display
characterist
undifferenti
transform
cell
caus
sever
muscl
wast
weight
loss
aulino
et
al
studi
augment
nk
nkt
cell
activ
innat
immun
respons
cell
metastas
liver
target
mice
mortal
subsequ
decreas
tolllik
receptor
associ
immun
respons
initi
cancer
cell
recent
precis
respons
initi
activ
unclear
new
studi
demonstr
matrix
metalloproteinas
significantli
elev
immun
respons
factor
induc
signal
pancreat
cancer
cell
discuss
type
iii
interferon
attract
idea
antivir
antitumor
therapi
due
type
ilik
effect
addit
potenti
decreas
sideeffect
precis
case
effect
compar
type
interferon
effect
hepatocellular
carcinoma
hcc
cancer
link
chronic
hepat
b
infect
tian
et
al
use
pegyl
peg
found
inhibit
hcc
antitumor
activ
significantli
decreas
toxic
side
effect
must
note
peg
accomplish
standard
tian
et
al
pegyl
interferon
use
therapi
hepat
multipl
sclerosi
largers
pegyl
interferon
increas
length
time
interferon
abl
exert
biolog
effect
baker
pegyl
interferon
larger
due
addit
polyethylen
glycol
peg
previous
discuss
studi
lu
et
al
mutant
demonstr
antiprolif
effect
gastric
cell
line
also
demonstr
mutant
display
enhanc
antitumor
activ
hepatoma
line
lu
et
al
ifn
incorpor
neuroendocrin
tumor
studi
potenti
antitumor
medic
due
signal
similar
use
neuroendocrin
carcinoma
therapi
proven
induc
antiprolif
effect
neuroendocrin
tumor
induct
pathway
zitzmann
et
al
show
ifn
induc
signal
pathway
antiprolif
effect
cell
commonli
use
cell
line
pancreat
neuroendocrin
tumor
research
vandamm
et
al
zitzmann
et
al
studi
zitmann
et
al
also
elucid
neg
regul
mechan
cytokin
demonstr
suppressor
cytokin
signal
soc
protein
complet
suppress
antiprolif
effect
caus
ifn
soc
play
signific
role
elucid
neg
regul
mechan
cytokin
area
studi
spars
compar
knowledg
posit
cytokin
regul
larsen
glioblastoma
also
shown
antitumor
effect
human
glioblastoma
line
meager
et
al
heterodim
receptor
present
multipl
human
glioblastoma
cell
line
express
much
greater
magnitud
cell
signific
cell
line
express
signific
level
unrespons
respons
dosespecif
highlight
weak
tissu
specif
ifn
compar
type
interferon
recent
discoveri
usher
new
era
cytokin
research
cytokin
ifn
rel
focu
intens
studi
field
antivir
immunotherapi
research
structur
similar
famili
member
signal
similar
share
type
interferon
vandamm
et
al
instantli
suggest
potenti
antivir
antiprolif
immunomodulatori
capabl
vast
array
studi
past
thirteen
year
solidifi
hypothes
abil
mediat
innat
adapt
immun
respons
virus
tumor
coupl
decreas
side
effect
due
limit
cellular
target
make
import
cytokin
consider
antivir
immunotherapi
research
move
futur
author
conflict
interest
